Presage Biosciences, Inc. — Form D
Presage Biosciences, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-22. The offering totals $3.2M, of which $3.2M was reported sold. Industry: Other Technology.
Offering
- Filed: 2010-03-22
- Form: D
- Accession: 0001485311-10-000002
- Industry: Other Technology
- Exemptions: 06
- Total offering: $3.2M
- Amount sold: $3.2M
- Minimum investment: $1
- Investors: 45
- Date of first sale: 2010-03-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-139820
Issuer
- Name: Presage Biosciences, Inc.
- CIK: 0001485311
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 530 FAIRVIEW AVENUE, N., SEATTLE, WA, 98109
- Phone: 1-800-530-5404
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Thane Kreiner | Director | Seattle, WA |
| Thane Kreiner | Executive Officer | Seattle, WA |
| James C Towne | Director | Seattle, WA |
| James C Towne | Executive Officer | Seattle, WA |
| Caitlin Cameron | Director | Bellevue, WA |
| Caitlin Cameron | Executive Officer | Bellevue, WA |
| James M Olson | Director | Seattle, WA |
| Ken K Nussbacher | Director | Seattle, WA |
| Scott K Murano | Executive Officer | Seattle, WA |
| Nathan C Caffo | Executive Officer | Seattle, WA |
| George J Todara | Director | Seattle, WA |
| George J Todaro | Director | Seattle, WA |
Other filings by this issuer (3)
More